AAAAAA

   
Results: 1-13 |
Results: 13
TARGETED CHEMOTHERAPY BY INTRATUMOR INJECTION OF ENCAPSULATED CELLS ENGINEERED TO PRODUCE CYP2B1, AN IFOSFAMIDE ACTIVATING CYTOCHROME-P450
Authors: LOHR M MULLER P KARLE P STANGE J MITZNER S JESNOWSKI R NIZZE H NEBE B LIEBE S SALMONS B GUNZBURG WH
Citation: M. Lohr et al., TARGETED CHEMOTHERAPY BY INTRATUMOR INJECTION OF ENCAPSULATED CELLS ENGINEERED TO PRODUCE CYP2B1, AN IFOSFAMIDE ACTIVATING CYTOCHROME-P450, Gene therapy, 5(8), 1998, pp. 1070-1078
SYSTEMIC LONG-TERM DELIVERY OF ANTIBODIES IN IMMUNOCOMPETENT ANIMALS USING CELLULOSE SULFATE CAPSULES CONTAINING ANTIBODY-PRODUCING CELLS
Authors: PELEGRIN M MARIN M NOEL D DELRIO M SALLER R STANGE J MITZNER S GUNZBURG WH PIECHACZYK M
Citation: M. Pelegrin et al., SYSTEMIC LONG-TERM DELIVERY OF ANTIBODIES IN IMMUNOCOMPETENT ANIMALS USING CELLULOSE SULFATE CAPSULES CONTAINING ANTIBODY-PRODUCING CELLS, Gene therapy, 5(6), 1998, pp. 828-834
LONG-TERM CULTIVATION OF IMMORTALIZED MOUSE HEPATOCYTES IN A HIGH CELL-DENSITY, FIXED-BED REACTOR
Authors: FASSNACHT D ROSSING S STANGE J PORTNER R
Citation: D. Fassnacht et al., LONG-TERM CULTIVATION OF IMMORTALIZED MOUSE HEPATOCYTES IN A HIGH CELL-DENSITY, FIXED-BED REACTOR, Biotechnology techniques, 12(1), 1998, pp. 25-30
TARGETED CHEMOTHERAPY WITH ENCAPSULATED, GENETICALLY-MODIFIED CELLS ENGINEERED TO PRODUCE CYP2B1, AN IFOSFAMIDE CONVERTING-ENZYME
Authors: MULLER P KARLE P JESNOWSKI R SALLER R MITZNER S STANGE J LIEBE S SALMONS B GUNZBURG WH LOHR M
Citation: P. Muller et al., TARGETED CHEMOTHERAPY WITH ENCAPSULATED, GENETICALLY-MODIFIED CELLS ENGINEERED TO PRODUCE CYP2B1, AN IFOSFAMIDE CONVERTING-ENZYME, Gastroenterology, 114(4), 1998, pp. 2672-2672
TARGETED CHEMOTHERAPY BY INTRATUMORAL INJECTION OF ENCAPSULATED CELLSENGINEERED TO PRODUCE AN IFOSFAMIDE ACTIVATING CYTOCHROME-P450, CYP2B1
Authors: LOHR M MULLER P KARLE P STANGE J MITZNER S JESNOWSKI R NEBE B NIZZE H LIEBE S SALMONS B GUNZBURG WH
Citation: M. Lohr et al., TARGETED CHEMOTHERAPY BY INTRATUMORAL INJECTION OF ENCAPSULATED CELLSENGINEERED TO PRODUCE AN IFOSFAMIDE ACTIVATING CYTOCHROME-P450, CYP2B1, Cancer gene therapy, 4(5), 1997, pp. 303-303
CELLS IN MICROCAPSULES - INTRACORPOREAL A ND EXTRACORPOREAL APPLICATIONS FOR ORGAN REPLACEMENT AND SENSOR SYSTEM
Authors: STANGE J MITZNER S
Citation: J. Stange et S. Mitzner, CELLS IN MICROCAPSULES - INTRACORPOREAL A ND EXTRACORPOREAL APPLICATIONS FOR ORGAN REPLACEMENT AND SENSOR SYSTEM, European journal of cell biology, 74, 1997, pp. 37-37
PREDICTION OF IN-VIVO DRUG-INTERACTION FROM IN-VITRO SYSTEMS EXEMPLIFIED BY INTERACTION BETWEEN VERAPAMIL AND CIMETIDINE USING HUMAN LIVER-MICROSOMES AND PRIMARY HEPATOCYTES
Authors: FISCHER U ROHDE B WACK R STANGE J NITSCHKE FP ADAM U DREWELOW B
Citation: U. Fischer et al., PREDICTION OF IN-VIVO DRUG-INTERACTION FROM IN-VITRO SYSTEMS EXEMPLIFIED BY INTERACTION BETWEEN VERAPAMIL AND CIMETIDINE USING HUMAN LIVER-MICROSOMES AND PRIMARY HEPATOCYTES, Journal of clinical pharmacology, 37(12), 1997, pp. 1150-1159
A CARRIER-MEDIATED TRANSPORT OF TOXINS IN A HYBRID MEMBRANE - SAFETY BARRIER BETWEEN A PATIENTS BLOOD AND A BIOARTIFICIAL LIVER
Authors: STANGE J MITZNER S
Citation: J. Stange et S. Mitzner, A CARRIER-MEDIATED TRANSPORT OF TOXINS IN A HYBRID MEMBRANE - SAFETY BARRIER BETWEEN A PATIENTS BLOOD AND A BIOARTIFICIAL LIVER, International journal of artificial organs, 19(11), 1996, pp. 677-691
CELL SOURCES FOR BIOARTIFICIAL LIVER SUPPORT
Authors: STANGE J MITZNER S
Citation: J. Stange et S. Mitzner, CELL SOURCES FOR BIOARTIFICIAL LIVER SUPPORT, International journal of artificial organs, 19(1), 1996, pp. 14-17
HEPATOCYTE ENCAPSULATION - INITIAL INTENTIONS AND NEW ASPECTS FOR ITSUSE IN BIOARTIFICIAL LIVER SUPPORT
Authors: STANGE J MITZNER S
Citation: J. Stange et S. Mitzner, HEPATOCYTE ENCAPSULATION - INITIAL INTENTIONS AND NEW ASPECTS FOR ITSUSE IN BIOARTIFICIAL LIVER SUPPORT, International journal of artificial organs, 19(1), 1996, pp. 45-48
ROLE OF TRANSPORT PROTEINS IN BIOARTIFICIAL LIVER ASSIST SYSTEMS
Authors: MITZNER S STANGE J FREYTAG J LINDEMANN S SCHIMIDT R
Citation: S. Mitzner et al., ROLE OF TRANSPORT PROTEINS IN BIOARTIFICIAL LIVER ASSIST SYSTEMS, International journal of artificial organs, 19(1), 1996, pp. 49-52
PROLONGED BIOCHEMICAL AND MORPHOLOGICAL STABILITY OF ENCAPSULATED LIVER-CELLS - A NEW METHOD
Authors: STANGE J MITZNER S DAUTZENBERG H RAMLOW W KNIPPEL M STEINER M ERNST B SCHMIDT R KLINKMANN H
Citation: J. Stange et al., PROLONGED BIOCHEMICAL AND MORPHOLOGICAL STABILITY OF ENCAPSULATED LIVER-CELLS - A NEW METHOD, Biomaterials, artificial cells, and immobilization biotechnology, 21(3), 1993, pp. 343-352
DIALYSIS AGAINST A RECYCLED ALBUMIN SOLUTION ENABLES THE REMOVAL OF ALBUMIN-BOUND TOXINS
Authors: STANGE J RAMLOW W MITZNER S SCHMIDT R KLINKMANN H
Citation: J. Stange et al., DIALYSIS AGAINST A RECYCLED ALBUMIN SOLUTION ENABLES THE REMOVAL OF ALBUMIN-BOUND TOXINS, Artificial organs, 17(9), 1993, pp. 809-813
Risultati: 1-13 |